Blog
RSS FeedPosted by Michael Wonder on 16 Jan 2020
Epilepsy deaths: level of risk in medication brand switch unclear, study says
17 January 2020 - Five deaths in people with epilepsy following a brand switch may be part of an under-represented level ...
Posted by Michael Wonder on 16 Jan 2020
U.S. targets drug pricing, no-poach deals for anti-trust action in 2020
15 January 2020 - Justice Department antitrust chief also promises decision on music licensing, criticizes states’ lawsuit against T-Mobile and Sprint. ...
Posted by Michael Wonder on 12 Jan 2020
Atomoxetine – further delay in change of funded brand and open access
10 January 2020 - PHARMAC is advising all interested parties that there is a further delay in the listing of ...
Posted by Michael Wonder on 09 Jan 2020
California eyes selling its own brand of generic prescription drugs to battle high costs
9 January 2020 - California would become the first state to sell its own brand of generic prescription drugs in ...
Posted by Michael Wonder on 09 Jan 2020
PHARMAC epilepsy drug process questions
10 January 2020 - There are many unanswered questions about PHARMAC's decision to fund only one brand of the epilepsy ...
Posted by Michael Wonder on 06 Jan 2020
Generic makers will appeal ruling that allows California to proceed with law banning pay-to-delay deals
3 January 2020 - A federal judge dealt the pharmaceutical industry a setback by declining to block a new California ...
Posted by Michael Wonder on 05 Jan 2020
'The public deserves to know why' - National intensifies calls for inquiry into PHARMAC after fifth death linked to epilepsy drug Logem
2 January 2020 - The National Party has intensified its call for a ministerial inquiry into PHARMAC's decision to switch ...
Posted by Michael Wonder on 24 Dec 2019
FDA approves first generics of Eliquis
23 December 2019 - The U.S. FDA has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce ...
Posted by Michael Wonder on 19 Dec 2019
Request for information on lamotrigine brand change
9 December 2019 - The request, dated 15 November 2019, asked for all and any advice or information or guidance that ...
Posted by Michael Wonder on 17 Dec 2019
PHARMAC brand switch: man driving through Waterview Tunnel blacked out
18 December 2019 - An Auckland man had a seizure and blacked out as he drove through Auckland's Waterview Tunnel after ...
Posted by Michael Wonder on 17 Dec 2019
Calls for answers about PHARMAC delay after epilepsy deaths
17 December 2019 - The Opposition is calling for answers from the Government about why it took two weeks for ...
Posted by Michael Wonder on 17 Dec 2019
Lamotrigine NPPA change
17 December 2019 - The request seeks all ‘communications’ between members of the PHARMAC senior leadership team, and in anticipation ...
Posted by Michael Wonder on 14 Dec 2019
FDA issues new analysis linking greater generic competition and lower generic drug prices
13 December 2019 - Greater competition among generic drug makers is associated with lower generic drug prices, according to a new ...
Posted by Michael Wonder on 10 Dec 2019
Endo launches generic version of Afinitor (everolimus) tablets in the United States
10 December 2019 - Endo International today announced that one of its operating companies, Par Pharmaceutical, has received approval for and ...
Posted by Michael Wonder on 05 Dec 2019
FDA approves first generics of Gilenya
5 December 2019 - The U.S. FDA has approved three applications for first generics of Gilenya (fingolimod) capsules for the ...